Advanced search
Publication Cover
Colorectal Cancer Volume 4, 2015 - Issue 2
Submit an article Journal homepage
2,325
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Defining resectability of colorectal liver metastases

Simon George Fisher1 Liver Surgery Unit, Aintree University Hospital, Lower Lane, Liverpool L9 7AL, UK
,
Koert Kuhlmann1 Liver Surgery Unit, Aintree University Hospital, Lower Lane, Liverpool L9 7AL, UK
&
Graeme Poston1 Liver Surgery Unit, Aintree University Hospital, Lower Lane, Liverpool L9 7AL, UKCorrespondence[email protected]
Pages 55-57 | Published online: 16 Apr 2015

References

  • Stangl R , Altendorf-HofmannA, CharnleyRM, ScheeleJ. Factors influencing the natural history of colorectal liver metastases. Lancet343(89), 1405–1410 (1994).
  • Fong Y , FortnerJ, SunRL, BrennanMF, BlumgartLH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg.230(3), 309–318, discussion 318–321 (1999).
  • Fong Y . Surgical therapy of hepatic colorectal metastasis. CA Cancer J. Clin.49(4), 231–255 (1999).
  • Poston GJ , AdamR, AlbertsSet al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J. Clin. Oncol.23(28), 7125–7134 (2005).
  • Gallagher DJ , KemenyN. Metastatic colorectal cancer: from improved survival to potential cure. Oncology78(3–4), 237–248 (2010).
  • Leporrier J , MaurelJ, ChicheL, BaraS, SegolP, LaunoyG. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br. J. Surg.93(4), 465–474 (2006).
  • Chun YS , VautheyJ-N, RiberoDet al. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J. Gastrointest. Surg.11(11), 1498–1504, discussion 1504–1505 (2007).
  • Vauthey J-N , PawlikTM, RiberoDet al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol.24(13), 2065–2072 (2006).
  • Adam R , PascalG, CastaingDet al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann. Surg. 240(6), 1052–1061, discussion 1061–1064 (2004).
  • Carpizo DR , AreC, JarnaginWet al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann. Surg. Oncol.16(8), 2138–2146 (2009).
  • Adam R , DelvartV, PascalGet al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg.240(4), 644–657, discussion 657–658 (2004).
  • Alberts SR , HorvathWL, SternfeldWCet al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group Phase II study. J. Clin. Oncol.23(36), 9243–9249 (2005).
  • Evrard S , PostonG, Kissmeyer-NielsenPet al. Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. PLoS ONE9(12), e114404 (2014).
  • Yip VS , PostonGJ, FenwickSW, WieshmannH, AthwalT, MalikHZ. FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases. Eur. J. Surg. Oncol.40(8), 995–999 (2014).
  • Abdalla EK . Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome. J. Surg. Oncol.102(8), 960–967 (2010).
  • Schadde E , SchnitzbauerAA, TschuorC, RaptisDA, BechsteinWO, ClavienP-A. Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy. Ann. Surg. Oncol. doi:10.1245/s10434-014-4213-5 (2014) ( Epub ahead of print).
  • Jakobs TF , HoffmannR-T, DehmKet al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J. Vasc. Interv. Radiol.19(8), 1187–1195 (2008).
  • Vouche M , LewandowskiRJ, AtassiRet al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J. Hepatol.59(5), 1029–1036 (2013).
  • Whitney R , TatumC, HahlMet al. Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J. Surg. Res.166(2), 236–240 (2011).
  • Hagness M , FossA, LineP-Det al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann. Surg.257(5), 800–806 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.